Eledon Pharmaceuticals (ELDN) Gains from Investment Securities (2016)
Historic Gains from Investment Securities for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q4 2016 value amounting to -$11000.0.
- Eledon Pharmaceuticals' Gains from Investment Securities changed N/A to -$11000.0 in Q4 2016 from the same period last year, while for Sep 2017 it was -$11000.0, marking a year-over-year change of. This contributed to the annual value of $431000.0 for FY2024, which is N/A changed from last year.
- Latest data reveals that Eledon Pharmaceuticals reported Gains from Investment Securities of -$11000.0 as of Q4 2016.
- In the past 5 years, Eledon Pharmaceuticals' Gains from Investment Securities registered a high of $2.1 million during Q4 2014, and its lowest value of -$11000.0 during Q4 2016.
- Moreover, its 4-year median value for Gains from Investment Securities was $218417.0 (2014), whereas its average is $725892.0.
- As far as peak fluctuations go, Eledon Pharmaceuticals' Gains from Investment Securities soared by 9098.8% in 2014, and later crashed by 3086.62% in 2015.
- Over the past 4 years, Eledon Pharmaceuticals' Gains from Investment Securities (Quarter) stood at $1.1 million in 2013, then soared by 90.99% to $2.1 million in 2014, then tumbled by 92.97% to $151000.0 in 2015, then crashed by 107.28% to -$11000.0 in 2016.
- Its Gains from Investment Securities was -$11000.0 in Q4 2016, compared to $151000.0 in Q3 2015 and $2.1 million in Q4 2014.